Vanguard罗素1000指数ETF VONE 深 沪
已收盘 05-08 16:00:00 美东时间
332.81
+2.500
+0.76%
华盛通- 最 高333.05
- 今 开332.09
- 成交量 8.38万股
- 最 低 331.74
- 昨 收 330.31
- 总市值 788.59万
- 52周最高 333.05
- 市盈率 静 --
- 换手率 353.75%
- 52周最低 258.1638
- 委 比 48.15%
- 总股本 2.37万
- 历史最高 333.05
- 量 比 0.83
- 振 幅 0.40%
- 历史最低 54.9562
- 每 手 1
- 风险率 16.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Goldman rebalances its long duration stock basket
The Goldman Sachs equity team has rebalanced its Long Duration Basket amid a recent rise in rates. "Equities usually struggle to digest sharp increases in interest rates, with long duration growth sto...
04-16 19:28
BRIEF-Novonesis Issues EUR 1.7 Billion In Bonds To Refinance Bridge Facility
BRIEF-Novonesis Issues EUR 1.7 Billion In Bonds To Refinance Bridge Facility March 16 (Reuters) - Novozymes A/S NSISb.CO : NOVONESIS ISSUES EUR 1.7 BILLION IN BONDS TO REFINANCE BRIDGE FACILITY NOVONESIS - BOND ISSUANCE TO REFINANCE BRIDGE FACILITY FOR FEED ENZYME ALLIANCE ACQUISITION Source text: I
03-16 20:21
BRIEF-Shionogi & Co Ltd - Planned Acquisition Of Global Rights To Tanabe Pharma's RADICAVA ORS And IV RADIC
Dec 22 (Reuters) - Shionogi & Co Ltd 4507.T: SHIONOGI EXPANDS RARE DISEASE PRESENCE WITH PLANNED ACQUISITION OF GLOBAL RIGHTS TO TANABE PHARMA CORPORATION'S RADICAVA ORS (EDARAVONE) AND IV RADIC TO PA...
2025-12-22 18:06
Best AI productivity beneficiary stocks - Goldman
Goldman Sachs has identified a new group of “AI productivity beneficiaries,” highlighting companies best positioned to see earnings lift from automation-driven efficiency gains. Strategist David Kosti...
2025-11-18 21:52
BRIEF-Novonesis And Noma In Partnership
Oct 23 (Reuters) - Novozymes A/S NSISb.CO: NOMA AND NOVONESIS PARTNER TO SCALE DELICIOUSNESS Source text: https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251023:nGNE8...
2025-10-23 19:06
BRIEF-Summit Therapeutics Raises $500 Million in Private Placement
Oct 22 (Reuters) - Summit Therapeutics Inc SMMT.O: SUMMIT THERAPEUTICS RAISES $500 MILLION IN PRIVATE PLACEMENT SUMMIT THERAPEUTICS INC - TO USE PROCEEDS FOR IVONESCIMAB DEVELOPMENT SUMMIT THERAPEUTIC...
2025-10-22 20:12
BRIEF-Novonesis And Novo Nordisk Will Explore New Solutions To Improve Metabolic Health
Sept 8 (Reuters) - Novozymes A/S NSISb.CO: NOVONESIS AND NOVO NORDISK WILL EXPLORE NEW SOLUTIONS TO IMPROVE METABOLIC HEALTH Source text: ID:nGNX6Lm3t7 Further company coverage: [NSISb.CO] ((Reuters.B...
2025-09-08 14:43
BRIEF-Revolution Medicines And Summit Therapeutics Enter Into Clinical Collaboration To Evaluate Combinations Of Three Ras(On) Inhibitors With Ivonescimab In Ras Mutant Tumors
Revolution Medicines Inc RVMD.O: REVOLUTION MEDICINES AND SUMMIT THERAPEUTICS ENTER INTO CLINICAL COLLABORATION TO EVALUATE COMBINATIONS OF THREE RAS(ON) INHIBITORS WITH IVONESCIMAB IN RAS MUTANT TUMO...
2025-06-30 20:15
Biogen Inc. Reports Q1 2025: Adjusted Earnings Per Share and Sales Growth Amid Currency Challenges
Biogen Inc. has released its financial results for the first quarter of 2025, reporting key figures and business updates. The company recorded a substantial increase in sales, driven by strong perform...
2025-05-01 18:47
BRIEF-ACS' FlatironDragados Integrates New York Tri-State Area Businesses
March 6 (Reuters) - ACS Actividades de Construccion y Servicios SA ACS.MC: FLATIRONDRAGADOS INTEGRATES NEW YORK TRI-STATE AREA BUSINESSES TRANSACTION EXPECTED TO BE COMPLETED IN Q2 FLATIRONDRAGADOS TO...
2025-03-06 23:48
